Bausch Health Companies Inc. company info

CIK 885590
IRS Number 000000000
State of incorporation NJ
Business address 2150 ST. ELZEAR BLVD. WEST
LAVAL
QUEBEC
A8
H7L 4A8
Mail address 2150 ST. ELZEAR BLVD. WEST
LAVAL
QUEBEC
A8
H7L 4A8

Short summary

Bausch Health Companies Inc. is a Quebec, Canada company, with head office located at 2150 St. Elzear Blvd. West Quebec, Quebec, Canada H7L 4A8. In 2018 the company owned a total of 32.49 billion USD worth of assets, including 4.21 billion USD worth of current assets. 2014 was the year when the company amassed the most assets.

Bausch Health Companies Inc. Income Statement

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Selling, General and Administrative Expense 188.92167.63276.55572.47756.081,305.202,0262,7002,8102,5822,473
Operating Income (Loss) 124.11181.15-110.09299.9679.70-409.502,0011,527-566102-2,384
Other Nonoperating Income (Expense) 263-295-7335321
Income Tax Expense (Benefit) -73-1.50-28.07-177.56-278.20-450.80174.20133-27-4,145-10

Bausch Health Companies Inc. Balance Sheet

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 433.6452.92176.57238.95395.272,539.40531.209588521,214838721
Accounts Receivable, Net, Current 234.02468.54769.471,676.402,075.802,686.90
Inventories 88.13259.78388.73497.06942.501,229.501,336.701,084993934
Property, Plant and Equipment, Gross 404.46540.03636.232,0732,290.202,625.802,5082,8332,875
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 122.71125.79173.51838.80977.901,1841,1961,4301,522
Goodwill 100.293,358.923,724.345,277.809,436.3017,233.1018,511.8015,89213,28313,142
Available-for-sale Securities, Noncurrent 9.177.17
Intangible Assets, Net (Excluding Goodwill) 1,263.996,959.918,121.569,289.6711,751.4023,149.7021,335.8017,51613,39312,001
Other Assets, Noncurrent 29.4653.6289.51199.44206.30167219.40111124109
Total assets 2,029.7211,827.8714,019.8219,782.2627,895.6048,343.2047,662.2041,73334,44832,492
Current assets 414.441,045.691,630.234,532.035,163.706,345.205,818.405,9924,6394,211
Accounts payable 41.88126.71156.18284.54327.70415.80425.90371417411
Total current liabilities 234.24761.891,049.201,761.822,496.304,2914,226.404,4654,0743,836
Long-term Debt, Excluding Current Maturities 302.944,529.297,356.0210,447.2317,058.8030,290.2030,773.2027,64824,85824,077
Long-term Debt 4,546.797,551.1810,794.1117,325.5030,881.1031,067.3028,46125,08824,305
Deferred Revenue, Noncurrent 59.4542.5137.9036.13
Deferred income taxes 1,251.091,229.031,261.132,238.806,152.805,879.205,434
Total liabilities 669.047,162.4610,324.3914,079.7322,528.3041,784.8042,259.1037,70430,89029,677
Common Stock, Value, Issued 1,468.255,872.995,885.238,250.198,325.909,880.809,914.9010,08510,11410,121
Retained Earnings (Accumulated Deficit) -330.51-244.67-1,887.34-2,245.89-2,429.05-3,175.30-2,387.90-3,425.70-4,539-4,970-5,664
Accumulated Other Comprehensive Income (Loss), Net of Tax 25.6742.04282.93-226.97-343.90-104.70-1,291.50-1,573.70-1,965-2,068-2,137

Bausch Health Companies Inc. Cash Flow

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Depreciation and amortization 149.26254.50612.60986.222,015.801,737.602,4672,8662,8582,819
Depreciation 18.8023.9045.6054.80113.80187210193168175
Amortization of Intangible Assets 113.91228.93566.99931.441,901.98
Deferred Income Tax Expense (Benefit) -90-16-55.40-217.45-341.73-534.2023.5056-268-4,311-337
Accounts receivable -26.6527.00-25.19164.58219.43261.3857262634-417-216
Inventories -16.2933.58-7.4611.5280.30122.70193276164-75
Accounts payable -6.1430.77-76.10-8.98
Deferred revenue -11.11-13.11-2.82-3.63
Net Cash Provided by (Used in) Operating Activities 204.33360.90263.19656.601,0422,294.702,2572,0872,2901,501
Payments to Acquire Property, Plant, and Equipment 22.007.4216.8258.52107.64115.30292235235171157
Payments to Acquire Productive Assets 7.4216.8258.52107.60115.30292235235171157
Payments to Acquire Businesses, Net of Cash Acquired -308.982,464.113,485.305,253.501,10215,458190
Payments to Acquire Intangible Assets 761.8384.53327.4473.5069.60179685616578
Net Cash Provided by (Used in) Investing Activities -107.83-742.77228.94-2,965.70-5,380.30-99.70-15,577-1252,887-196
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -742.77228.94-2,844.51-2,965.72-5,380.39
Proceeds from Issuance of Long-term Debt 350992.405,388.806,005.808,385.401,63017,8171,2209,4248,944
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.8758.4341.7223.026.4016303302
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.8758.4341.7223.026.4016303302
Proceeds from Issuance of Common Stock 002,307.4001,43300
Payments for Repurchase of Common Stock 29.8460.13639.24280.7055.6007200
Payments of Ordinary Dividends, Common Stock 180.29147.15356.29
Net Cash Provided by (Used in) Financing Activities -210.31177.05-213.283,057.304,027.70-2,46013,624-1,963-4,963-1,353
Cash and Cash Equivalents, Period Increase (Decrease) -116.09-203.08279.81